Related Funds
Fund Name | Location |
Alive Ideas | France, Ile-de-France, Paris |
Amelia Investments | - |
AWTG | - |
BAE Systems | Farnborough, Hampshire, United Kingdom |
Burda International | Bayern, Germany, Munich |
Calyon Financial | Chicago, Illinois, United States |
Huaneng Capital | Beijing, Beijing, China |
Kempen & Co | Amsterdam, Noord-Holland, The Netherlands |
LVMH Luxury Ventures | France, Ile-de-France, Paris |
MAR ventures | Brazil, São Paulo, Sao Paulo |
Movistar | Community of Madrid, Madrid, Spain |
Partners HealthCare Innovation | Cambridge, Massachusetts, United States |
ROCA Partners | Beverly Hills, California, United States |
San Diego Venture Partners | - |
Sanderling Ventures | California, San Mateo, United States |
Successful Ventures | Barcelona, Catalonia, Spain |
TDM Growth Partners | Australia, New South Wales, Sydney |
Theodorus III | - |
Weston Presidio Capital | Boston, Massachusetts, United States |
Yakumi | Japan, Tokyo |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
U Power | 18 May 2023 | Xuhui, Shanghai, China | |||
Ubrigene | $15M | 01 Sep 2022 | - | ||
Puguang Bio | $13M | 11 Jul 2022 | Nanjing, Jiangsu, China | ||
GenFleet Therapeutics | $77M | 31 Dec 2021 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
U Power | 18 May 2023 | Xuhui, Shanghai, China | |||
Ubrigene | $15M | 01 Sep 2022 | - | ||
Puguang Bio | $13M | 11 Jul 2022 | Nanjing, Jiangsu, China | ||
GenFleet Therapeutics | $77M | 31 Dec 2021 | Shanghai, China |